Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma

Summary

The thrombin generation test is used to study coagulation in patients with haemorrhagic diseases or with high thrombotic risk. To our knowledge, this is the first study investigating the relative influence of coagulation factors on thrombin generation in plasma. The aim was to investigate the influence of coagulant factors, anticoagulant factors, and tissue factor (TF) on three parameters: endogenous thrombin potential (ETP), peak thrombin concentration, and lag time for the appearance of thrombin. At a low TF concentration, all factors except factor XI influenced thrombin generation. At a high TF concentration, only the factors of the extrinsic pathway exerted an influence. ETP and peak thrombin were linearly correlated to factor II concentration. Factor V and factor VII effects increased hyperbolically with factor concentration. The influence of factor X on thrombin generation depended onTF concentration. In the absence of factorVIII and factor IX, ETP fell to 60–70% of the normal when peak thrombin fell to 25–30% of the normal. Fibrinogen concentration influenced ETP and peak thrombin and decreasing fibrinogen levels shortened the lag time. As expected, decreasing antithrombin concentration caused dramatic increases in thrombin generation. Protein S prolonged the lag time, especially at a low TF concentration. No effect of protein C was observed, likely due to the absence of thrombomodulin. The thrombin generation test was more sensitive to factor deficiencies at low than at high TF concentration. ETP was not the most critical parameter for studying coagulation factor deficiencies. Instead, peak thrombin was the most sensitive parameter.

Keywords

Anticoagulant factor - procoagulant factor - thrombin generation - tissue factor

• References

• 1 Hron G, Kollars Binder BR. et al. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. J Am Med Assoc 2006; 296: 397-402.
• 2 Hemker HC, Wielders S, Kessels H. et al. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-624.
• 3 Hemker HC, Giesen PL, Ramjee M. et al. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 2000; 83: 589-591.
• 4 Hemker HC, Giesen P, Al Dieri R. et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
• 5 Xi M, Béguin S, Hemker HC. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemost 1989; 62: 788-791.
• 6 Butenas S, van’t Veer C, Mann KG. „Normal” thrombin generation. Blood 1999; 94: 2169-2178.
• 7 Al Dieri R, Peyvandi F, Santagostino E. et al. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002; 88: 576-582.
• 8 Duchemin J, Pittet JL, Tartary M. et al. A new assay based on thrombin generation inhibition to detect both protein C and protein S deficiencies in plasma. Thromb Haemost 1994; 71: 331-338.
• 9 Bevers EM, Comfurius P, Zwaal RF. Changes in membrane phospholipid distribution during platelet activation. Biochem Biophys Acta 1983; 736: 57-66.
• 10 Mayer LD, Hope MJ, Cullis PR. Vesicles of variables sizes produced by a rapid extrusion procedure. Biochim Biophys Acta 1986; 858: 161-168.
• 11 Chantarangkul V, Clerici M, Bressi C. et al. Thrombin generation assessed as endogenous potential in patients with hyper- or hypo-coagulability. Haematologica 2003; 88: 547-554.
• 12 Josso F, Prou-Wartelle O. Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thromb Diath Haemorr. 1965 17 35-44.
• 13 Osterud B, Rapapaort SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-5264.
• 14 Zur M, Nemerson Y. Kinetics of factor IX activation via the extrinsic pathway. Dependence of Km on tissue factor. J Biol Chem 1980; 255: 5703-5707.
• 15 Butenas S, van’t Veer C, Mann KG. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J Biol Chem 1997; 272: 21527-21533.
• 16 Wielders SJH, Ungethüm L, Reutelingsperger CPM. et al. Factor Xa-driven thrombin generation in plasma: dependency on the aminophospholipid density of membranes and inhibition by phospholipid-binding proteins. Thromb Haemost 2007; 98: 105-108.
• 17 Beltran-Miranda CP, Khan A, Jaloma-Cruz AR. et al. Thrombin generation and phenotypic correlation in haemophilia A. Haemophilia 2005; 11: 326-334.
• 18 Devreese K, Wijns W, Combes I. et al. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis. Thromb Haemost 2007; 98: 600-613.
• 19 Dargaud Y, Bordet JC, Francillon S. et al. Haemophilia patients exhibit prolonged coagulation time but normal lag time of thrombin generation test: are these results really discordant?. Thromb Haemost 2007; 97: 675-676.
• 20 Dargaud Y, Béguin S, Lienhart A. et al. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost 2005; 93: 475-480.
• 21 Giansily-Blaizot M, Al Dieri R, Schved JF. Thrombin generation measurement in factor VII-depleted plasmas compared to inherited factor VII-deficient plasmas. Pathophysiol Haemost Thromb 2003; 33: 36-42.
• 22 Keularts IMLW, Zivelin A, Seligsohn U. et al. The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost 2001; 85: 1060-1065.
• 23 Kumar R, Béguin S, Hemker HC. The influence of fibrinogen and fibrin on thrombin generation – Evidence for feedback activation of the clotting system by clot bound thrombin. Thromb Haemost 1994; 72: 713-721.
• 24 Mosesson MW. Update on antithrombin I (fibrin). Thromb Haemost 2007; 98: 105-108.
• 25 Seré KM, Rosing J, Hackeng TM. Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance. Blood 2004; 104: 3624-3630.
• 26 Van Wijnen M, van’t Veer C, Meijers JCM. et al. A plasma coagulation assay for an activated protein C-independent anticoagulant activity of protein S. Thromb Haemost 1998; 80: 930-935.
• 27 Hackeng TM, van’t Veer C, Meijers JCM. et al. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. J Biol Chem 1994; 269: 21051-21058.
• 28 van’t Veer C, Butenas S, Golden NJ. et al. Regulation of prothrombinase activity by protein S. Thromb Haemost 1999; 82: 80-87.
• 29 Hemker HC, Al Dieri R, de Smedt E. et al. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 2006; 96: 553-561.
• 30 Butenas S, Mann KG. Caution in the interpretation of continuous thrombin generation assays. J Thromb Haemost 2007; 5: 1084-1085.
• 31 Lan A, Berry LR, Mitchell LG. et al. Effect of substrate and fibrin polymerisation inhibitor on determination of plasma thrombin generation in vitro. Thromb Res 2007; 119: 667-677.
• 32 Hemker HC, De Smedt E. Caution in the interpretation of continuous thrombin generation assays: a rebuttal. J Thromb Haemost 2007; 5: 1085-1087.